Henk M. Lokhorst - Concepedia

Author

Henk M. Lokhorst

Also Known As

Axel, Amy, Benoît Liquet, H Lokhorst, Henk Lokhorst, Henk M Lokhorst, Henk M. Lokhorst, Lokhorst, Henk M, Raymond L Comenzo, Xavier LeLeu

304

Publications

18.5K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Amsterdam UMC Location Vrije Universiteit Amsterdam Erasmus MC Utrecht University Janssen (United States)

About

Henk M. Lokhorst is an author at University Medical Center Utrecht specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	1.5K
2	Health Sciences	6	6	203
3	Natural Sciences	1	1	241
4	Nursing	1	1	21
5	Social Sciences	1	1	78

Henk M. Lokhorst

125

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, Journal of Clinical Oncology	2015	2.1K
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, New England Journal of Medicine	2015	1.1K
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors Michel de Weers, Yu‐Tzu Tai, Michael S. van der Veer, The Journal of Immunology	2010	996
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma Jakub Krejcik, Tineke Casneuf, Inger S. Nijhof, Blood	2016	890
Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt, Journal of Clinical Oncology	2012	819
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma Saad Z. Usmani, Brendan M. Weiss, Torben Plesner, Blood	2016	399
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma Inger S. Nijhof, Tineke Casneuf, Jeroen van Velzen, Blood	2016	371
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p Kai Neben, Henk M. Lokhorst, Anna Jauch, Blood	2011	353
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients Annemiek Broyl, Dirk Hose, Henk M. Lokhorst, Blood	2010	336
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells Patrick W.B. Derksen, Esther P.M. Tjin, Helen P. Meijer, Proceedings of the National Academy of Sciences	2004	301

Page 1